Vicks once again achieved the top monthly spot for TV impressions, while iSpot noted that pharma brands generated more year-over-year returns from sports and news cables compared to 2023.
We performed a multivariate analysis of risk factors for CHF using data from the Multinational Etoricoxib and Diclofenac Arthritis Long ... Novartis, and Bayer, and has received grants from ...
Bayer Zydus Pharma will start operations with ... Exemptia to treat auto immune disorders such as rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosing ...
Roche and research support from the German Arthritis Foundation (Deutsche Rheumastiftung). AH received ad board honoraria from Novartis, Chugai-Roche and SOBI. IF has received ad board honoraria from ...
Pain Management Market Advancements in non-opioid therapies, AI-integrated solutions, and regenerative <a target=_blank href= ...
Faced with huge debt, the impending expiry of a crucial patent, and ongoing litigation over a horror acquisition, Bayer CEO Bill Anderson made a bold move a year ago to get his damaged company ...
Since becoming Bayer's CEO, Bill Anderson has introduced striking changes to the company, including an overhaul of its budget system, which he sees as the driving source of corporate bureaucracy.
Bill Anderson has shaken up Bayer employees’ day-to-day since taking charge in 2023. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site ...
A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals known as PCBs at a Seattle-area school, but found the company was not ...
Bayer was founded in the year 1863 in Barmen in North Rhine Westphalia in the west of what was then the Kingdom of Prussia, today modern Germany. "What started as a small but innovative dyestuffs ...
Bayer's booth presents regenerative agriculture products during the seventh China International Import Expo in Shanghai in November. TANG YANJUN/CHINA NEWS SERVICE Bayer Crop Science, one of the ...